<p><strong>Pediatric Use</strong>: Safety and effectiveness in pediatric patients have not been established.<br />
<br />
<strong>Geriatric Use</strong>: Approximately 90% of the patients treated with Verteporfin in the clinical efficacy trials were over the age of 65. A reduced treatment effect was seen with increasing age.</p>